Laboratorija - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 4,806 | 5,302 | 4,396 | 5,313 | 6,474 | 8,135 | 8,438 | 5,243 |
| Profit before tax | -480 | 30 | 346 | -872 | 220 | 439 | 1,008 | 1,527 |
| Net profit | -480 | 30 | 346 | -872 | 220 | 439 | 971 | 1,435 |
| Equity | -131 | -101 | 245 | -629 | -409 | 30 | 1,001 | 2,473 |
| Liabilities | - | - | - | - | 583 | 1,419 | 509 | 572 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 205 | 426 | 1,255 | 418 | 174 | 1,449 | 1,510 | 3,045 |
| Total assets | 205 | 426 | 1,255 | 418 | 174 | 1,449 | 1,510 | 3,045 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | - | - | 37 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +27.6% | +10.3% | -17.1% | +20.9% | +21.9% | +25.7% | +3.7% | -37.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -234.1% | 7.0% | 27.6% | -208.6% | 126.4% | 30.3% | 64.3% | 47.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | 141.2% | - | - | 1463.3% | 97.0% | 58.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -10.0% | 0.6% | 7.9% | -16.4% | 3.4% | 5.4% | 11.5% | 27.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -10.0% | 0.6% | 7.9% | -16.4% | 3.4% | 5.4% | 11.9% | 29.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | 47.3 | 0.5 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Laboratorija - Social security debts
The amount of overdue SODRA debt for the company Laboratorija as of the last working day is: 80 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-15 | 2026-09-15 | 80.10 |
| 2026-09-05 | 2026-09-14 | 80.48 |
| 2026-09-01 | 2026-09-02 | 80.48 |
| 2026-08-16 | 2026-08-16 | 160.96 |
| 2026-08-01 | 2026-08-14 | 160.96 |
| 2026-06-02 | 2026-07-31 | 80.48 |
| 2026-05-03 | 2026-05-31 | 80.48 |
| 2026-04-01 | 2026-04-30 | 80.48 |
| 2026-03-03 | 2026-03-31 | 88.51 |
| 2026-02-03 | 2026-03-02 | 8.03 |
| 2025-12-02 | 2026-01-31 | 72.45 |
| 2025-09-02 | 2025-11-30 | 72.45 |
| 2025-06-03 | 2025-08-31 | 72.45 |
| 2025-05-04 | 2025-05-31 | 72.45 |
| 2025-02-01 | 2025-04-30 | 72.45 |
| 2025-01-02 | 2025-01-31 | 64.50 |
| 2024-10-04 | 2024-10-31 | 129.00 |
| 2024-10-02 | 2024-10-03 | 330.46 |
| 2024-10-01 | 2024-10-01 | 428.44 |
| 2024-09-17 | 2024-09-30 | 461.92 |
| 2024-09-04 | 2024-09-16 | 494.90 |
| 2024-09-03 | 2024-09-03 | 960.88 |
| 2024-08-14 | 2024-09-02 | 896.38 |
| 2024-08-12 | 2024-08-13 | 950.56 |
| 2024-08-01 | 2024-08-11 | 950.56 |
| 2024-07-12 | 2024-07-31 | 886.06 |
| 2024-07-02 | 2024-07-11 | 886.06 |
| 2024-06-11 | 2024-07-01 | 821.56 |
| 2024-06-03 | 2024-06-10 | 821.56 |
| 2024-05-15 | 2024-06-02 | 757.06 |
| 2024-05-02 | 2024-05-14 | 64.50 |
| 2024-04-03 | 2024-04-30 | 64.50 |
| 2024-02-01 | 2024-03-31 | 64.50 |
| 2024-01-03 | 2024-01-31 | 58.63 |
| 2023-12-07 | 2023-12-31 | 111.72 |
| 2023-12-01 | 2023-12-06 | 117.26 |
| 2023-11-03 | 2023-11-30 | 58.63 |
| 2023-01-03 | 2023-01-31 | 50.95 |
| 2022-12-14 | 2022-12-31 | 49.75 |
| 2022-11-03 | 2022-12-13 | 50.95 |
| 2022-10-03 | 2022-10-31 | 50.95 |
| 2022-09-19 | 2022-09-30 | 18.08 |
| 2022-09-14 | 2022-09-18 | 50.95 |
| 2022-09-01 | 2022-09-13 | 101.90 |
| 2022-08-02 | 2022-08-31 | 50.95 |
| 2022-06-01 | 2022-06-30 | 50.95 |
| 2022-05-13 | 2022-05-31 | 31.00 |
| 2022-05-03 | 2022-05-12 | 50.95 |
| 2022-03-02 | 2022-04-30 | 50.95 |
| 2022-03-01 | 2022-03-01 | 82.33 |
| 2022-02-15 | 2022-02-28 | 42.49 |
| 2022-02-09 | 2022-02-14 | 50.95 |
| 2022-02-02 | 2022-02-08 | 55.70 |
| 2022-02-01 | 2022-02-01 | 61.52 |
| 2022-01-24 | 2022-01-31 | 10.57 |
| 2022-01-14 | 2022-01-23 | 40.04 |
| 2022-01-05 | 2022-01-13 | 44.81 |
| 2022-01-03 | 2022-01-04 | 85.22 |
| 2021-12-13 | 2021-12-31 | 40.41 |
| 2021-11-04 | 2021-12-12 | 44.81 |
| 2021-10-01 | 2021-10-31 | 7.32 |
Laboratorija - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-08-01 | 2025-08-25 | 0.01 |
| 2025-07-02 | 2025-07-20 | 0.14 |
| 2025-07-01 | 2025-07-01 | 37.14 |
| 2025-06-19 | 2025-06-30 | 37.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Laboratorija, MB (code 303349191) is a small partnership operating in activities of advertising agencies. In the latest financial year, 2025, the company generated revenue of €5.2K and net profit of €1.4K, resulting in a profit margin of 27.4%. Revenue declined by 37.9% year on year, after a relatively stable prior period with €8.1K in 2023 and €8.4K in 2024, while profitability strengthened steadily from €439 in 2023 to €971 in 2024 and €1.4K in 2025. The balance sheet also expanded in 2025, with total assets of €3.0K, equity of €2.5K and liabilities of €572. Equity accounted for 81.2% of assets, and debt remained low with a debt-to-equity ratio of 0.23. Asset turnover was 1.72x, indicating that the company used its asset base to generate revenue efficiently. Return on equity was 58.0% and return on assets 47.1% in 2025.